Rhythm Pharmaceuticals (RYTM) Shares Issued (2017 - 2025)
Historic Shares Issued for Rhythm Pharmaceuticals (RYTM) over the last 9 years, with Q3 2025 value amounting to -$22.9 million.
- Rhythm Pharmaceuticals' Shares Issued fell 53737.34% to -$22.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.3 million, marking a year-over-year increase of 18734.79%. This contributed to the annual value of $39.1 million for FY2024, which is 1990.59% down from last year.
- Rhythm Pharmaceuticals' Shares Issued amounted to -$22.9 million in Q3 2025, which was down 53737.34% from $34.0 million recorded in Q1 2025.
- In the past 5 years, Rhythm Pharmaceuticals' Shares Issued ranged from a high of $161.7 million in Q1 2021 and a low of -$22.9 million during Q3 2025
- Moreover, its 5-year median value for Shares Issued was $5.8 million (2024), whereas its average is $28.0 million.
- Its Shares Issued has fluctuated over the past 5 years, first surged by 28286000.0% in 2022, then crashed by 53737.34% in 2025.
- Quarter analysis of 5 years shows Rhythm Pharmaceuticals' Shares Issued stood at -$5000.0 in 2021, then soared by 282860.0% to $14.1 million in 2022, then soared by 239.38% to $48.0 million in 2023, then tumbled by 45.48% to $26.2 million in 2024, then tumbled by 187.46% to -$22.9 million in 2025.
- Its Shares Issued stands at -$22.9 million for Q3 2025, versus $34.0 million for Q1 2025 and $26.2 million for Q4 2024.